Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07238023 · ClinicalTrials.gov registry record · NA
Promoting Active Living Among People With Metastatic Breast Cancer
A NA study of Metastatic Invasive Breast Cancer, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT07238023 is a NA study of Metastatic Invasive Breast Cancer that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 38 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07238023, a NA study of Metastatic Invasive Breast Cancer, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activity is generally safe for this population and may alleviate symptom burden. Yet, limited interventions are tailored to the unique and needs and preferences of this population. This study aims to evaluate the acceptability and feasibility of a mindfulness- and acceptance-based physical activity program designed to support mental, social, and spiritual well-being among people with metastatic breast cancer. A single group, pretest-posttest trial (N=38) will be conducted to inform scalable strategies to promote active living and enhance quality of life among people with advanced cancer.
Conditions Studied
Interventions
- BEHAVIORAL Acceptance- and mindfulness-based physical activity promotion
Study Locations (1)
Oklahoma
- TSET Health Promotion Research Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2026-02-27 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07238023
The ClinicalTrials.gov registry entry for NCT07238023 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Invasive Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Acceptance- and mindfulness-based physical activity promotion is the first listed.
NCT07238023 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07238023 about?
NCT07238023 is a clinical study titled "Promoting Active Living Among People With Metastatic Breast Cancer". Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activity is generally safe for this population and may alleviate symptom burden. Yet, limited interventions are tailored to the unique and needs and...
What is the current status of trial NCT07238023?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-02-27. Estimated completion is 2026-06.
What conditions does trial NCT07238023 study?
This clinical trial studies the following conditions: Metastatic Invasive Breast Cancer.
What interventions are being tested in trial NCT07238023?
The interventions under investigation include: Acceptance- and mindfulness-based physical activity promotion (BEHAVIORAL).
Who is sponsoring clinical trial NCT07238023?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07238023 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.